ArticlePharmacoEconomics2006

Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in Germany.

Peter K Schädlich et al.PubMed ↗Publisher ↗

No numbers read from the abstract.